Table: Torii Pharmaceutical - Q1 parent results
Apr 30 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2020 Mar 31, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.57 9.16 41.60
(+4.5 pct) (-34.2 pct) (-3.3 pct)
Operating 1.25 loss 709 mln 3.00
(+109.7 pct)
Recurring 1.32 loss 656 mln 3.30
(+95.0 pct)
Net 862 mln 28.52 2.10
(-97.0 pct) (-92.3 pct)
EPS 30.74 yen 1,016.43 yen 74.80 yen
EPS Diluted 30.73 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)